BCR and B-cell chronic lymphocytic leukemia: BCR inhibitors induce mild cell apoptosis and have substantial cytostatic effects shown by interfering with CLL cell entrance to lymph nodes to obtain proproliferative CLL–T cell interactions (12, 37).